Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis

Patients with localized (that is non-metastatic) pancreatic ductal adenocarcinoma with an inadequate response or toxicity to first-line chemotherapy may benefit from chemotherapy switch. The aim was to explore the available data on the use and effect of chemotherapy switch, as reported in the litera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of surgery 2024-10, Vol.111 (10)
Hauptverfasser:	Dekker, Esther N, Narayan, Raja R, Ahmami, Mohamed A, Meddouch, Anis, Verkolf, Eva M M, Gehrels, Anne M, Besselink, Marc G H, van Eijck, Casper H J, Homs, Marjolein Y V, Mostert, Bianca, O'Kane, Grainne M, de Wilde, Roeland F, Wilmink, Johanna W, O'Reilly, Eileen M, Qadan, Motaz, Groot Koerkamp, Bas
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - mortality Carcinoma, Pancreatic Ductal - pathology Carcinoma, Pancreatic Ductal - surgery Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Drug Substitution Fluorouracil - administration & dosage Fluorouracil - therapeutic use Gemcitabine Humans Leucovorin - administration & dosage Leucovorin - therapeutic use Oxaliplatin - administration & dosage Oxaliplatin - therapeutic use Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Pancreatic Neoplasms - surgery Systematic Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!